AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpy-MF 2 Tablet

Prescription Icon
Prescription Required

Marketer

Astra Labs

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimpy-MF 2 Tablet

DiabetaComb 2 tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. This treatment helps regulate blood glucose. DiabetaComb 2 should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue this medication even with controlled blood sugar; discontinuation without medical guidance can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan that includes diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect. Learn to identify symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Regular meals and carrying fast-acting glucose (e.g., sugary snacks or juice) are crucial. Alcohol increases hypoglycemia risk and should be avoided. Other possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your physician of any heart history before starting. Pregnancy or breastfeeding requires medical consultation. Regular blood glucose monitoring, along with blood cell and liver function tests, may be recommended by your doctor.

Uses of Glimpy-MF 2 Tablet

Managing type 2 diabetes

Major Benefits of Glimpy-MF 2 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimpy-MF 2 Tablet with a meal.

Common Side effects of Glimpy-MF 2 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimpy-MF 2 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpy-MF 2 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Glimpy-MF 2 Tablet works:

Glimbet-Duo tablets contain a dual-action formulation of glimepiride and metformin, both effective in managing blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpy-MF 2 Tablet and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimpy-MF 2 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Administering Glimpy-MF 2 Tablet while breastfeeding is contraindicated. Evidence indicates potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimpy-MF 2 Tablet to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimpy-MF 2 Tablet is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimpy-MF 2 Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimpy-MF 2 Tablet :

Should you forget a Glimpy-MF 2 Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpy-MF 2 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimpy-MF 2 Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, or others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential complication of Glimpy-MF 2 Tablet use. Also termed Metformin-associated lactic acidosis (MALA), this rare but dangerous side effect is particularly concerning for individuals with pre-existing kidney impairment, the elderly, or those who consume substantial amounts of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia necessitate immediate cessation of Glimpy-MF 2 Tablet intake and prompt medical attention.
The dual-component Glimpy-MF 2 Tablet, containing Glimepiride and Metformin, manages type 2 diabetes mellitus (DM) in adults. Its efficacy in reducing blood glucose relies on adherence to a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus decreasing blood glucose. Metformin acts by reducing hepatic glucose production and enhancing insulin responsiveness. This formulation is unsuitable for type 1 DM.
Taking Glimpy-MF 2 Tablet may result in common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, and headaches. Less frequent, but potentially severe, adverse reactions include lactic acidosis. Prolonged treatment might also cause a deficiency in vitamin B12.
Prolonged Glimpy-MF 2 Tablet use can indeed lead to Vitamin B12 deficiency due to impaired stomach absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications including peripheral neuropathy (manifested as tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at minimum annually, has been proposed by some investigators.
Indeed, Glimpy-MF 2 Tablet can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Glimpy-MF 2 Tablet is unsafe due to the risk of significantly reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Glimpy-MF 2 Tablet
74
MRP 90
17% off